St. John's Wort
St. John's Wort induces CYP1A2, the primary metabolic pathway for olanzapine. This can reduce olanzapine levels, causing psychotic relapse.
Recommendation: Avoid St. John's Wort with olanzapine.
Prescription ·Strong evidence ·Reviewed May 2026
Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar I disorder (manic or mixed episodes), and in combination with fluoxetine for treatment-resistant depression. Highly effective for psychotic symptoms but carries the highest metabolic risk among atypical antipsychotics, including significant weight gain, dyslipidemia, and risk of new-onset diabetes. Dosage must be determined by your prescribing physician.
The bottom line
Evidence rating strong. Most-documented uses: strong psychotic symptom control, bipolar mania treatment, treatment-resistant depression (with fluoxetine). 10 sources indexed (2008–2024), with 4 interaction records on file.
Core mechanism
Antagonizes multiple neurotransmitter receptors including dopamine D1–D4, serotonin 5-HT2A/2C/3/6, histamine H1, muscarinic M1–M5, and alpha-1 adrenergic receptors. The broad receptor binding profile accounts for both its clinical efficacy and significant metabolic side effects. 5-HT2C and H1 antagonism are particularly implicated in weight gain and metabolic effects.
Can be taken with or without food. Well absorbed orally. IM injection available for acute agitation.2
St. John's Wort induces CYP1A2, the primary metabolic pathway for olanzapine. This can reduce olanzapine levels, causing psychotic relapse.
Recommendation: Avoid St. John's Wort with olanzapine.
THC-dominant cannabis can undermine olanzapine treatment by increasing relapse risk and worsening psychosis outcomes. Systematic reviews link continued cannabis use in psychosis with more relapse, poorer adherence, and antipsychotic treatment failure. The combination can also add impairment and sleepiness in people already sensitive to olanzapine sedation.
Recommendation: Avoid THC-dominant cannabis while taking olanzapine for psychosis or mood stabilization. If cannabis use continues, your prescriber should know so relapse risk, adherence, and sedation can be monitored. Dose timing separation is not a reliable safety strategy.
Alcohol can add to olanzapine-related sedation, slowed reaction time, dizziness, and impaired coordination. Olanzapine can already cause sleepiness and orthostatic symptoms, so alcohol increases the chance of falls, unsafe driving, blackouts, and accidental injury. The risk is higher during dose starts or increases, in older adults, or with other sedating medicines.
Recommendation: Avoid alcohol while taking olanzapine, especially during titration or if you already feel sleepy. If you drink despite this, do not drive or use machinery and do not take extra sedatives. Seek urgent help for severe confusion, slow breathing, repeated falls, or inability to wake.
Melatonin has been studied as an adjunct to reduce some metabolic side effects of olanzapine, including weight and cardiometabolic changes. Randomized trials and meta-analyses suggest possible benefit, but the effects are modest and do not replace diet, activity, or metabolic monitoring. Melatonin may also add bedtime sleepiness in patients who already feel sedated on olanzapine.
Recommendation: Use melatonin with olanzapine only as an adjunct, preferably at bedtime and with your prescriber's awareness. Continue routine weight, glucose, lipid, and blood-pressure monitoring. Reduce or stop melatonin and ask for guidance if morning grogginess, falls, or worsening daytime sedation occurs.
Numbered references. Citations throughout the page link here.
Gupta D, Singh A. Olanzapine-Samidorphan for Schizophrenia: A Systematic Review and Meta-Analysis. Indian journal of psychological medicine. 2024
Gannon L, Reynolds J, Mahon M et al.. High-dose olanzapine in treatment-resistant schizophrenia: a systematic review. Therapeutic advances in psychopharmacology. 2023
Wang Z, Feng Y, Wang Y et al.. Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia. Computational and mathematical methods in medicine. 2022
Jawad MY, Alnefeesi Y, Lui LMW et al.. Olanzapine and samidorphan combination treatment: A systematic review. Journal of affective disorders. 2022
Han R, Bian Q, Chen H. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis. Brain and behavior. 2022
Goetz RL, Miller BJ. Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine. Schizophrenia research. 2019
Kantrowitz JT, Citrome L. Olanzapine: review of safety 2008. Expert opinion on drug safety. 2008
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.